TMBIM4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.09819999655403E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.43790000017852E-07 |
Normal-vs-Stage2 |
3.01069999997239E-06 |
Normal-vs-Stage3 |
1.023330E-03 |
Normal-vs-Stage4 |
8.961300E-03 |
Stage1-vs-Stage2 |
7.353800E-01 |
Stage1-vs-Stage3 |
4.845600E-01 |
Stage1-vs-Stage4 |
5.303000E-01 |
Stage2-vs-Stage3 |
4.339800E-01 |
Stage2-vs-Stage4 |
3.994000E-01 |
Stage3-vs-Stage4 |
8.988400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.3907000046286E-08 |
Normal-vs-AfricanAmerican |
9.67859999999598E-05 |
Normal-vs-Asian |
7.535900E-03 |
Caucasian-vs-AfricanAmerican |
3.198000E-01 |
Caucasian-vs-Asian |
9.442600E-01 |
AfricanAmerican-vs-Asian |
7.937600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.67000000494966E-08 |
Normal-vs-Female |
1.92208999999499E-05 |
Male-vs-Female |
2.893400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.40889999999694E-05 |
Normal-vs-Extreme_Weight |
2.70919999767472E-08 |
Normal-vs-Obese |
1.89490000002124E-06 |
Normal-vs-Extreme_Obese |
3.64610000003207E-06 |
Normal_Weight-vs-Extreme_Weight |
5.279600E-01 |
Normal_Weight-vs-Obese |
6.656600E-01 |
Normal_Weight-vs-Extreme_Obese |
1.074190E-01 |
Extreme_Weight-vs-Obese |
8.856800E-01 |
Extreme_Weight-vs-Extreme_Obese |
1.222390E-01 |
Obese-vs-Extreme_Obese |
1.626000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.814000E-04 |
Normal-vs-Age(41-60Yrs) |
1.62150000004857E-06 |
Normal-vs-Age(61-80Yrs) |
4.08789999628567E-08 |
Normal-vs-Age(81-100Yrs) |
6.783900E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.146000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.123200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.790800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.227200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.015000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.859600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.51289999972271E-07 |
Normal-VS-Type2 PRCC |
2.94479999995989E-06 |
Normal-VS-KIRP CIMP |
2.2283999999706E-06 |
Normal-VS-Unclassified PRCC |
1.404310E-04 |
Type1 PRCC-VS-Type2 PRCC |
7.375000E-01 |
Type1 PRCC-VS-KIRP CIMP |
6.920300E-02 |
Type1 PRCC-VS-Unclassified PRCC |
7.211800E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.383160E-01 |
Type2 PRCC-VS-Unclassified PRCC |
6.026000E-01 |
KIRP CIMP-VS-Unclassified PRCC |
6.425800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.78750000356942E-08 |
Normal-vs-N1 |
1.643760E-02 |
Normal-vs-N2 |
5.741600E-01 |
N0-vs-N1 |
1.964830E-01 |
N0-vs-N2 |
3.403800E-02 |
N1-vs-N2 |
4.471200E-01 |
|
|